NCT01294423 - Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

261

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Type 2 DiabetesHigh Blood Sugar

Interventions

DRUG

Dapagliflozin

Dapagliflozin 5mg/matching placebo for Dapagliflozin 10mg oral dose

DRUG

Dapagliflozin

Dapagliflozin 10mg/matching placebo for Dapagliflozin 5mg oral dose

DRUG

Placebo

Matching placebo for Dapagliflozin 5mg/10mg oral dose

Trial Locations (26)

Unknown

Research Site, Noda

Research Site, Fukuoka

Research Site, Yukuhashi

Research Site, Hiroshima

Research Site, Chitose-shi

Research Site, Sapporo

Research Site, Takasago-shi

Research Site, Hakusan-shi

Research Site, Sanuki-shi

Research Site, Takamatsu

Research Site, Ebina-shi

Research Site, Kamakura-shi

Research Site, Sendai

Research Site, Matsumoto-shi

Research Site, Okayama

Research Site, Osaka

Research Site, Suita

Research Site, Ōtsu

Research Site, Shizuoka

Research Site, Chuo-ku

Research Site, Chūō

Research Site, Meguro-ku,

Research Site, Ōta-ku

Research Site, Tokyo

Research Site, Takaoka-shi

Research Site, Toyama